Crospovidone & CROSPOVIDONE, UNSPECIFIED Excipient Use in Tablet Orally Disintegrating Extended Release Dosage Forms

Crospovidone

DESCRIPTION

DESCRIPTION

Suppliers

21 Listed Products, 1 Microlex e.U, 1 Novo Excipients, 1 Alcedo Pharmachem, 1 Ulanqab Kema New Material, 1 Pharmatrans-Sanaq, 4 Gangwal Chemicals, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 4 Boai NKY Pharmaceuticals Ltd, 1 Kerry

REGULATORY FILINGS

17 Suppliers, 15 USDMF, 7 CEP/COS

SOLUTIONS BY APPLICATIONS

13 Disintegrants & Superdisintegrants, 7 Direct Compression, 5 Granulation, 4 Fillers, Diluents & Binders, 4 Chewable & Orodispersible Aids, 3 Thickeners and Stabilizers, 3 Solubilizers, 1 Film Formers & Plasticizers, 1 Co-Processed Excipients, 1 Taste Masking, 1 Coating Systems & Additives

REF. STANDARDS & IMPURITIES

1 Others

1 Others

FINISHED FORMULATIONS

396 ORAL, 294 TABLET, 27 CAPSULE, 26 TABLET, EXTENDED RELEASE, 21 TABLET, DELAYED RELEASE, 16 TABLET, ORALLY DISINTEGRATING, 5 SUBLINGUAL, 3 FOR SUSPENSION, 3 GRANULE, 2 CAPSULE, DELAYED REL PELLETS, 2 CAPSULE, EXTENDED RELEASE, 2 FOR SUSPENSION, DELAYED RELEASE, 1 CAPSULE, DELAYED RELEASE, 1 FILM, EXTENDED RELEASE, 1 SOLUTION, 1 SUSPENSION, EXTENDED RELEASE, 1 TABLET, COATED PARTICLES, 1 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 TRANSDERMAL